For example, it has been demonstrated that induced pluripotent stem cells (IPSCs)-derived DCs (iPSC-DCs) can enhance the immune response and potentially overcome resistance to anti-PD-L1 therapy in non-responsive tumour types (138). Here, CD274 is linked to neoplasm.